Method for determining the response of a malignant disease to an immunotherapy

The invention relates to a method for predicting the response of a malignant disease to an immunotherapy which inhibits the PD-1 immune checkpoint signal path. The method is characterized in that at least one part of an immuno-regulatory gene selected from CTLA4, CD86, CD28, CD80 and/or

Saved in:
Bibliographic Details
Main Author DIETRICH, Dimo
Format Patent
LanguageEnglish
Published 23.12.2021
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The invention relates to a method for predicting the response of a malignant disease to an immunotherapy which inhibits the PD-1 immune checkpoint signal path. The method is characterized in that at least one part of an immuno-regulatory gene selected from CTLA4, CD86, CD28, CD80 and/or
Bibliography:Application Number: AU20180360287